Success Metrics

Clinical Success Rate
97.0%

Based on 32 completed trials

Completion Rate
97%(32/33)
Active Trials
12(15%)
Results Posted
3%(1 trials)
Terminated
1(1%)

Phase Distribution

Ph phase_1
4
5%
Ph not_applicable
63
78%
Ph phase_2
7
9%
Ph phase_3
3
4%

Phase Distribution

4

Early Stage

7

Mid Stage

3

Late Stage

Phase Distribution77 total trials
Phase 1Safety & dosage
4(5.2%)
Phase 2Efficacy & side effects
7(9.1%)
Phase 3Large-scale testing
3(3.9%)
N/ANon-phased studies
63(81.8%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

94.1%

32 of 34 finished

Non-Completion Rate

5.9%

2 ended early

Currently Active

12

trials recruiting

Total Trials

81

all time

Status Distribution
Active(22)
Completed(32)
Terminated(2)
Other(25)

Detailed Status

Completed32
unknown25
Recruiting12
Not yet recruiting9
Enrolling by invitation1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
81
Active
12
Success Rate
97.0%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (5.2%)
Phase 27 (9.1%)
Phase 33 (3.9%)
N/A63 (81.8%)

Trials by Status

unknown2531%
completed3240%
not_yet_recruiting911%
recruiting1215%
enrolling_by_invitation11%
terminated11%
withdrawn11%

Recent Activity

Clinical Trials (81)

Showing 20 of 81 trialsScroll for more
NCT06931535Not Applicable

Remote Ischemic Conditioning for Acute Moderate Posterior Ischemic Stroke

Recruiting
NCT07531394Phase 3

Safety and Efficacy of Remote Ischemic Conditioning in Patients With Acute Myocardial Injury Following Acute Ischemic Stroke

Not Yet Recruiting
NCT07412249Not Applicable

Remote Ischemic Conditioning Plus Stenting for Symptomatic Carotid Artery Stenosis

Recruiting
NCT06033963Not Applicable

Safety and Efficacy of Remote Ischemic Conditioning in Patients With Carotid Artery Stenosis Undergoing Carotid EndArterectomy

Completed
NCT07273942Not Applicable

Remote Ischemic Postconditioning in Septic Shock

Not Yet Recruiting
NCT07272408Not Applicable

Remote Ischemic Conditioning in Patients Undergoing Primary Percutaneous Coronary Intervention

Completed
NCT07270887

The Long-term Effect of Remote Ischemic Conditioning on Main Organs in ASVCD Patients With Very High Risks

Recruiting
NCT03201575Not Applicable

REmote Ischemic COnditioning in Septic Shock

Completed
NCT05910242Not Applicable

Efficacy and Safety of Remote Ischemic Conditioning in the Treatment of Essential Hypertension (RICBP-EH)

Completed
NCT03899532Not Applicable

Remote Ischemic Conditioning in Traumatic Brain Injury

Withdrawn
NCT06826144Not Applicable

Chronic Remote Ischemic Conditioning in Small Infarctions Associated with Stent-assisted Coiling of Unruptured Intracranial Aneurysms

Not Yet Recruiting
NCT06306625Not Applicable

REmote COnditioning in Out-of-Hospital Cardiac Arrest

Recruiting
NCT03481777Not Applicable

Remote Ischemic Conditioning in Patients With Acute Stroke (RESIST)

Completed
NCT05982015Not Applicable

Efficacy Study II on Remote Ischemic Conditioning for the Prevention of Stroke-Associated Pneumonia

Completed
NCT04977869Not Applicable

Safety and Efficacy Study of Remote Ischemic Conditioning Combined With Endovascular Thrombectomy for Acute Ischemic Stroke Due to Large Vessel Occlusion of Anterior Circulation

Completed
NCT04400981Not Applicable

Clinical Trial on Remote Ischemic Conditioning in Acute Ischemic Stroke Within 9 Hours of Onset in Patients Ineligible to Recanalization Therapies

Completed
NCT03915782Not Applicable

Neuroprotective Effect of Remote Ischemic Conditioning in Ischemic Stroke Treated With Mechanical Thrombectomy

Completed
NCT06702644Not Applicable

Safety and Efficacy of Remote Ischemic Conditioning in Patients with Chronic Internal Carotid Artery Occlusion Receiving Hybird Surgery: a Pilot, Randomized Controlled Trial

Not Yet Recruiting
NCT06654921Not Applicable

Remote Ischemic Conditioning for the Treatment of Diabetic Kidney Disease

Not Yet Recruiting
NCT03484936Not Applicable

Safety and Efficacy of Remote Ischemic Conditioning in Patients With Spontaneous Intracerebral Hemorrhage

Not Yet Recruiting

Drug Details

Intervention Type
DEVICE
Total Trials
81